Santa Clara University

Sue Siegel

Sue Siegel

CEO, GE Ventures

Sue Siegel is CEO of GE Ventures, GE’s investing and innovation arm to drive growth for its start-up partners and GE. It includes healthymagination, GE’s commitment to enable better health for more people, and GE’s venture investing and innovation group that combines capital, technical and commercial expertise with GE's IP and global network of businesses.

Previously, as a financial VC, Ms. Siegel led investments in personalized medicine, digital health, and life sciences at Silicon Valley-based Mohr Davidow Ventures. Before her VC years, Ms. Siegel dedicated over 22 years driving the growth of breakthrough technologies at Bio-Rad, DuPont, Amersham, and Affymetrix  (NASDAQ: AFFX).  As President and Board Member of Affymetrix, Ms. Siegel built shareholder value, leading its transformation from a pre-revenue start up into a global, multi-billion-dollar market-cap genomics leader.   

Ms. Siegel has served on over a dozen private and public corporate boards.  She currently serves on the Boards of the National Venture Capital Association, Stanford Hospital Board’s IT Committee, and NIH’s National Center for Advancing Translational Sciences-Cures Acceleration Network; she serves on the Executive Committee of Santa Clara University’s Center for Science, Technology, and Society’s Board, and she is on Harvard Medical School’s Genetics Council.   She is a President’s Circle member of the National Academies of Science, a Henry Crown Fellow of the Aspen Institute, a member of YPO-WPO, and of Women Corporate Directors.  In the bestselling business book:  Multipliers: How The Best Leaders Make Everyone Smarter, Ms. Siegel was a featured “Multiplier” and was recognized as one of “The 100 Most Influential Women in Silicon Valley”.